Safety, Pharmacokinetics (PK) of AKT and MEK Combination
Clinical trial NCT01138085 · COMPLETED
Trial details
- NCT number
- NCT01138085
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-04
- Primary completion
- 2014-11-19
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.